PetLife Pharmaceuticals, Inc.
CIK 0001354591
Revenue (TTM)
$0
Q2 Jul 2018
Net Income (TTM)
−$3.03M
−530.8% YoY
Q2 Jul 2018
EPS Diluted (TTM)
—
Q2 Jul 2018
Gross Margin
—
Q2 Jul 2018
Operating Margin
—
Q2 Jul 2018
Net Margin
—
Q2 Jul 2018
Free Cash Flow (TTM)
−$591.21K
Q2 Jul 2018
Cash
$7.86K
Q2 Jul 2018
Total Debt
—
Q2 Jul 2018
Shares Outstanding
196.75M sh
Q2 Jul 2018
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.